POU4F2 can also induce the expression of CCD1 and CDK4 in the context of proliferation and cell cycle progression [34,37], confer migratory and multidrug resistance properties to breast cancer in in vivo models [38], and cooperate with TP53 to increase transcription of pro-apoptotic genes [39]. The gene discussed is CDK4; the disease is breast cancer.